EP 1865777 A4 20080716 - STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
Title (en)
STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
Title (de)
ZUSAMMENSETZUNGEN UND VERABREICHUNG VON STANNSOPORFIN
Title (fr)
COMPOSITIONS DE STANNSOPORFINE ET ADMINISTRATION
Publication
Application
Priority
- US 2006012185 W 20060331
- US 9635905 A 20050401
- US 23976905 A 20050930
Abstract (en)
[origin: WO2006107806A2] Pharmaceutical compositions including stannsoporfin, drug products incorporating pharmaceutical compositions, methods of making pharmaceutical compositions, and methods of treating hyperbilirubinemia with drug products and compositions are disclosed.
IPC 8 full level
A61K 31/555 (2006.01); A61K 9/08 (2006.01); A61P 1/16 (2006.01)
CPC (source: EP KR)
A61K 9/0019 (2013.01 - EP); A61K 9/08 (2013.01 - KR); A61K 31/555 (2013.01 - EP KR); A61P 1/16 (2017.12 - EP)
Citation (search report)
- [DX] US 4692440 A 19870908 - KAPPAS ATTALLAH [US], et al
- [X] SHENOUDA MAGDY ET AL: "The pharmacokinetics (PK) of stannsoporfin in healthy adult volunteers are dose-proportionate", JOURNAL OF CLINICAL PHARMACOLOGY, vol. 44, no. 10, October 2004 (2004-10-01), & 33RD ANNUAL MEETING OF THE AMERICAN-COLLEGE-OF-CLINICAL-PHARMACOLOGY; PHOENIX, AZ, USA; OCTOBER 03 -05, 2004, pages 1186, XP008092154, ISSN: 0091-2700
- See references of WO 2006107806A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
BA HR MK YU
DOCDB simple family (publication)
WO 2006107806 A2 20061012; WO 2006107806 A3 20070712; AU 2006232330 A1 20061012; CA 2602794 A1 20061012; EP 1865777 A2 20071219; EP 1865777 A4 20080716; KR 20080004531 A 20080109; NO 20075508 L 20071031
DOCDB simple family (application)
US 2006012185 W 20060331; AU 2006232330 A 20060331; CA 2602794 A 20060331; EP 06749109 A 20060331; KR 20077024891 A 20071029; NO 20075508 A 20071031